| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $17.2B | $15.9B | $15.3B | $19.2B | $12.2B | $4.8B | $1.6B | $3.7B |
| Cost of Revenue | — | — | — | — | — | — | $2.8B | $4.4B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $2.6B | $2.9B | $3.7B | $6.0B | $2.8B | $-2.7B | $-0.6B | $1.1B |
| EPS (Basic) | $4.18 | $4.58 | $5.86 | $9.15 | $4.20 | $-7.12 | $-1.70 | $2.50 |
| EPS (Diluted) | $4.17 | $4.56 | $5.84 | $9.12 | $4.19 | $-7.12 | $-1.70 | $2.48 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $31.6B | $30.5B | $24.5B | $23.7B | $21.0B | $9.9B | $13.7B | $19.6B |
| Current Assets | $4.0B | $3.4B | $3.2B | $3.9B | $4.2B | $3.3B | $3.9B | $4.4B |
| Cash & Equivalents | $1.4B | $0.8B | $0.9B | $1.3B | $2.1B | $2.0B | $1.5B | $2.4B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $4.1B | $3.3B | $2.9B | $3.1B | $3.1B | $1.4B | $1.9B | $2.2B |
| Stockholders' Equity | $15.5B | $14.5B | $12.1B | $11.2B | $9.3B | $2.9B | $5.8B | $9.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $6.7B | $6.6B | $6.5B | — | — | — | — | — |
| Investing Cash Flow | $-3.4B | $-7.3B | $-3.9B | — | — | — | — | — |
| Capital Expenditures | — | — | — | — | — | — | $0.0B | $0.1B |
| Financing Cash Flow | $-2.7B | $0.7B | $-3.2B | — | — | — | — | — |